{"nctId":"NCT01125813","briefTitle":"Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A","startDateStruct":{"date":"2010-06"},"conditions":["Severe Hemophilia A"],"count":32,"armGroups":[{"label":"human cl-rhFVIII","type":"EXPERIMENTAL","interventionNames":["Biological: recombinant Factor VIII"]}],"interventions":[{"name":"recombinant Factor VIII","otherNames":["human-cl rhFVIII"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Severe hemophilia A ((FVIII:C \\<= 1%)\n* Male subjects \\>= 12 years of age\n* Previously treated with FVIII concentrate, at least 50 EDs\n* Immunocompetent (CD4+ count \\> 200/ul)\n* Negative for anti- HIV; if positive, viral load \\< 200 particles/u; or \\<400,000 copies/mL\n\nExclusion Criteria:\n\n* Other coagulation disorder than hemophilia A\n* Present of past FVIII inhibitor activity (.= 0.6 BU)\n* Severe liver and kidney disease\n* Receiving of scheduled to receive immuno-modulating drugs","healthyVolunteers":false,"sex":"MALE","minimumAge":"12 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Efficacy Assessment After a Total of at Least 50 EDs Per Subject at the End of the Study at 6 Months","description":"Frequency of spontaneous breakthrough bleeds/months under prophylactic treatment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.188","spread":"0.307"}]}]}]},{"type":"PRIMARY","title":"Efficacy of Treating Bleeding Episodes","description":"At the end of a bleeding episode, efficacy was assessed as:\n\n* Excellent: Abrupt pain relief and/or unequivocal improvement in objective signs of bleeding within approximately 8 hours after a single infusion\n* Good: Definite pain relief and/or improvement in signs of bleeding within approximately 8-12 hours after an infusion requiring up to 2 infusions for complete resolution\n* Moderate: Probable or slight beneficial effect within approximately 12 hours after the first infusion requiring more than two infusions for complete resolution\n* None: No improvement within 12 hours, or worsening of symptoms, requiring more than 2 infusions for complete resolution Efficacy was rated","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"71.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.6","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":32},"commonTop":["Nasopharyngitis","Headache","Abdominal pain","Diarrhoea","Nausea"]}}}